Candriam S.C.A. holds a diversified book of 692 stocks worth $19.3B as of Q1 2026 (disclosed Apr 30, 2026, a ~45-day 13F lag). This quarter they opened Service Corp International and trimmed Broadcom Inc. Their largest long position is Nvidia Corp at 6% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1537014/holdings"
Use Arkolith to show Candriam S.C.A.'s latest holdings, largest changes, and filing provenance.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Nvidia Corporation COM | $1.2B | 7.02M | 6.4% | ▲+3.9% Added · +262K sh | |
| 2 | Microsoft Corp COM | $991.4M | 2.68M | 5.2% | ▲+3.4% Added · +89K sh | |
| 3 | Apple Inc COM | $889.1M | 3.50M | 4.6% | ▲+4.5% Added · +150K sh | |
| 4 | Alphabet Inc CAP STK CL A | $742.7M | 2.58M | 3.9% | ▲+2.4% Added · +61K sh | |
| 5 | Amazon Com Inc COM | $528.1M | 2.54M | 2.7% | ▲+1.2% Added · +30K sh | |
| 6 | Broadcom Inc COM | $439.0M | 1.42M | 2.3% | ▼−1.0% Reduced · −15K sh | |
| 7 | Eli Lilly & Co COM | $383.8M | 417.3K | 2.0% | ▼−6.5% Reduced · −29K sh | |
| 8 | Abbvie Inc COM | $249.0M | 1.14M | 1.3% | ▲+6.2% Added · +67K sh | |
| 9 | Alphabet Inc CAP STK CL C | $246.4M | 859.1K | 1.3% | ▲+6.8% Added · +54K sh | |
| 10 | Gilead Sciences Inc COM | $232.8M | 1.67M | 1.2% | ▼−8.8% Reduced · −162K sh | |
| 11 | Taiwan Semiconductor Manufac SPONSORED ADS | $221.6M | 655.7K | 1.2% | ▼−14% Reduced · −108K sh | |
| 12 | McKesson Corp COM | $207.4M | 239.7K | 1.1% | ▲+17% Added · +34K sh | |
| 13 | Johnson & Johnson COM | $195.3M | 798.8K | 1.0% | ▲+6.6% Added · +49K sh | |
| 14 | Mastercard Incorporated CL A | $194.5M | 389.3K | 1.0% | ▼−6.7% Reduced · −28K sh | |
| 15 | Palo Alto Networks Inc COM | $192.2M | 1.20M | 1.0% | ▲+12% Added · +125K sh | |
| 16 | Lam Research Corp COM NEW | $185.1M | 866.5K | 1.0% | ▼−17% Reduced · −176K sh | |
| 17 | Visa Inc COM CL A | $176.4M | 583.7K | 0.9% | ▼−5.3% Reduced · −33K sh | |
| 18 | Thermo Fisher Scientific Inc COM | $174.0M | 354.1K | 0.9% | ▲+19% Added · +56K sh | |
| 19 | Micron Technology Inc COM | $173.8M | 514.4K | 0.9% | ▼−2.7% Reduced · −14K sh | |
| 20 | NextEra Energy Inc COM | $169.7M | 1.83M | 0.9% | ▲+54% Added · +641K sh | |
| 21 | Meta Platforms Inc CL A | $160.8M | 281.0K | 0.8% | ▲+12% Added · +31K sh | |
| 22 | Merck & Co Inc COM | $159.1M | 1.32M | 0.8% | ▲+3.7% Added · +47K sh | |
| 23 | Intuitive Surgical Inc COM NEW | $151.3M | 328.1K | 0.8% | ▲+13% Added · +37K sh | |
| 24 | Regeneron Pharmaceuticals COM | $144.0M | 186.4K | 0.7% | ▼−9.2% Reduced · −19K sh | |
| 25 | JPMorgan Chase & Co COM | $140.3M | 476.8K | 0.7% | ▼−23% Reduced · −146K sh | |
| 26 | Amgen Inc COM | $139.1M | 395.4K | 0.7% | ▲+0.9% Added · +4K sh | |
| 27 | Agilent Technologies Inc COM | $131.9M | 1.16M | 0.7% | ▲+27% Added · +244K sh | |
| 28 | Servicenow Inc COM | $121.7M | 1.16M | 0.6% | ▲+36% Added · +306K sh | |
| 29 | Advanced Micro Devices Inc COM | $120.5M | 592.1K | 0.6% | ▲+23% Added · +111K sh | |
| 30 | Xylem Inc COM | $116.5M | 974.9K | 0.6% | ▲+28% Added · +213K sh | |
| 31 | Ge Vernova Inc COM | $114.3M | 131.0K | 0.6% | ▲+57% Added · +47K sh | |
| 32 | Kla Corp COM NEW | $111.2M | 75.6K | 0.6% | ▲+243% Added · +54K sh | |
| 33 | Salesforce Inc COM | $109.8M | 588.4K | 0.6% | ▼−4.4% Reduced · −27K sh | |
| 34 | Tesla Inc COM | $109.1M | 293.4K | 0.6% | ▲+12% Added · +31K sh | |
| 35 | Procter & Gamble Co COM | $102.4M | 709.1K | 0.5% | ▲+5.9% Added · +40K sh | |
| 36 | Vertex Pharmaceuticals Inc COM | $102.2M | 228.9K | 0.5% | ▲+1.6% Added · +4K sh | |
| 37 | Home Depot Inc COM | $101.4M | 308.4K | 0.5% | ▲+5.3% Added · +15K sh | |
| 38 | Exelon Corp COM | $98.1M | 2.00M | 0.5% | ▲+66% Added · +799K sh | |
| 39 | Analog Devices Inc COM | $90.7M | 285.2K | 0.5% | ▼−8.3% Reduced · −26K sh | |
| 40 | On Semiconductor Corp COM | $86.4M | 1.39M | 0.4% | ▼−8.3% Reduced · −127K sh | |
| 41 | Wabtec COM | $82.8M | 331.5K | 0.4% | ▼−26% Reduced · −116K sh | |
| 42 | Boston Scientific Corp COM | $79.2M | 1.26M | 0.4% | ▲+12% Added · +132K sh | |
| 43 | Beone Medicines Ltd SPONSORED ADS | $77.1M | 259.7K | 0.4% | ▲+32% Added · +62K sh | |
| 44 | Keysight Technologies Inc COM | $76.6M | 271.4K | 0.4% | ▼−14% Reduced · −45K sh | |
| 45 | Morgan Stanley COM NEW | $76.0M | 461.9K | 0.4% | ▲+7.3% Added · +32K sh | |
| 46 | TJX Cos Inc New COM | $75.8M | 474.5K | 0.4% | ▼−8.1% Reduced · −42K sh | |
| 47 | Cadence Design System Inc COM | $75.7M | 272.5K | 0.4% | ▲+8.2% Added · +21K sh | |
| 48 | Monolithic PWR Sys Inc COM | $75.4M | 68.9K | 0.4% | ▼−27% Reduced · −26K sh | |
| 49 | Alnylam Pharmaceuticals Inc COM | $74.2M | 224.3K | 0.4% | —Held | |
| 50 | Schwab Charles Corp COM | $71.8M | 764.5K | 0.4% | ▲+15% Added · +99K sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | Apr 30, 2026 | 692 | $19.3B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Apr 30, 2026 | 685 | $20.1B | 13F-HR/A |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 | 665 | $19.1B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 | 679 | $17.3B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 799 | $16.0B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 7, 2025 | 791 | $17.4B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 689 | $17.4B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 5, 2024 | 810 | $16.5B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 6, 2024 | 702 | $15.6B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 704 | $14.5B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 | 844 | $14.1B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 | 903 | $13.8B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 | 1,076 | $14.4B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 13, 2023 | 1,050 | $14.8B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 | 1,066 | $14.2B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 | 966 | $12.1B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 996 | $14.7B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 10, 2022 | 997 | $15.7B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 9, 2021 | 1,076 | $14.7B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Jul 20, 2021 | 1,099 | $14.6B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | Apr 29, 2021 | 1,001 | $12.0B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Jan 22, 2021 | 998 | $12.6B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Oct 19, 2020 | 993 | $10.6B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.